BRIEF-Navamedic to launch non-invasive prenatal tests in Nordic markets

* Norwegian medtech and pharmaceutical products company, announced an agreement signed with Sequenom Laboratories of USA, a leading molecular diagnostics laboratory, for the launch of three non-invasive prenatal genetic tests in the Nordic region
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.